PSMC4 Activators

PSMC4 Activators is a term that refers to chemicals which can indirectly influence the function of the PSMC4 protein, a key component of the 26S proteasome complex involved in the ATP-dependent degradation of ubiquitinated proteins. The chemicals listed above, including bortezomib, carfilzomib, lactacystin, and MG132, among others, are primarily proteasome inhibitors. They do not directly activate PSMC4 but can influence its function by hindering the overall proteasomal activity.

These chemicals lead to an accumulation of polyubiquitinated proteins due to the inhibition of proteasomal degradation. As PSMC4 is part of the complex that is responsible for the degradation of these proteins, its function is indirectly affected by these chemicals. The range of chemicals includes specific inhibitors like lactacystin to broad-range inhibitors like PR-619, which influences PSMC4 indirectly by reducing the deubiquitination process. In essence, these PSMC4 Activators can manipulate the functional dynamics of the protein degradation pathway in which PSMC4 participates.